Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 171.5% in November

Posted by ABMN Staff on Nov 30th, 2024

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 103,700 shares, an increase of 171.5% from the October 31st total of 38,200 shares. Based on an average daily volume of 114,300 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a “strong-buy” rating in a research note on Friday, October 25th.

Get Our Latest Analysis on FSNUY

Fresenius SE & Co. KGaA Stock Up 0.2 %

FSNUY opened at $8.85 on Friday. Fresenius SE & Co. KGaA has a fifty-two week low of $6.57 and a fifty-two week high of $9.78. The firm has a market capitalization of $19.77 billion, a P/E ratio of 11.93 and a beta of 1.05. The company’s 50-day moving average is $9.10 and its 200 day moving average is $8.65. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.29 and a quick ratio of 1.00.

About Fresenius SE & Co. KGaA

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.